NPD Measurements in PSC Patients
NCT00476814 · Status: UNKNOWN · Type: OBSERVATIONAL
Last updated 2007-10-31
Summary
Primary Sclerosing Cholangitis (PSC) is a chronic disorder of the liver causing jaundice and liver damage. When Cystic Fibrosis affects the liver, the damaged liver looks like the liver in PSC. This study is designed to answer the question whether isolated PSC may be a form of CF only in the liver
Conditions
- Primary Sclerosing Cholangitis
Sponsors & Collaborators
-
Hadassah Medical Organization
lead OTHER
Principal Investigators
-
Michael Wilschanski, Dr · Hadassah Medical Organization
Eligibility
- Min Age
- 10 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- Israel
Study Locations
More Related Trials
-
Mitomycin C Therapy for Patients With Primary Sclerosing Cholangitis
NCT01688024 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of the Safety and Efficacy of HK-660S in Patients With Primary Sclerosing Cholangitis
NCT05866809 ·Status: COMPLETED ·Phase: PHASE2
-
Stem Cell Transplantation in Patients With Primary Biliary Cirrhosis
NCT00393185 ·Status: WITHDRAWN ·Phase: PHASE1
-
Norursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis
NCT01755507 ·Status: COMPLETED ·Phase: PHASE2
-
A Potential Novel Marker for Liver Fibrosis in NASH: the Soluble Secreted Form of the Human Asialoglycoprotein Receptor
NCT00941902 ·Status: COMPLETED
-
To Study the Efficacy of Bromocriptine in Patients With Hepatic/Cirrhosis Related Parkinsonism
NCT02265484 ·Status: COMPLETED ·Phase: NA
-
Safety and Tolerability of Cilofexor in Participants With Primary Sclerosing Cholangitis (PSC) and Compensated Cirrhosis
NCT04060147 ·Status: TERMINATED ·Phase: PHASE1
-
A POC and Dose-Ranging Study of HTD1801 in PSC Patients
NCT03333928 ·Status: COMPLETED ·Phase: PHASE2
-
The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland
NCT02846896 ·Status: COMPLETED
-
Sulfasalazine for the Treatment of Primary Sclerosing Cholangitis
NCT03561584 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Study of Xifaxan to Treat Patients With PSC
NCT01695174 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of HK-660S in the Treatment of Primary Sclerosing Cholangitis
NCT06975150 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Detoxification of the Liver In PSC (Dolphin)
NCT05835505 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
NCT06699121 ·Status: RECRUITING ·Phase: PHASE2
-
Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC)
NCT04480840 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Cilofexor in Adults With Primary Sclerosing Cholangitis
NCT03890120 ·Status: TERMINATED ·Phase: PHASE3
-
A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
NCT02932449 ·Status: COMPLETED
-
Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Sclerosing Cholangitis Without Cirrhosis
NCT02943460 ·Status: COMPLETED ·Phase: PHASE2
-
CM-101 in PSC Patients -The SPRING Study
NCT04595825 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study with Norucholic Acid Tablets in Patients with Primary Sclerosing Cholangitis (PSC)
NCT06886360 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation
NCT06905054 ·Status: RECRUITING ·Phase: PHASE2
-
CS0159 in Chinese Patients With PSC (Primary Sclerosing Cholangitis)
NCT05896137 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Mesenchymal Stem Cell Transplantation for Refractory Primary Biliary Cholangitis
NCT03668145 ·Status: UNKNOWN ·Phase: NA
-
norUrsodeoxycholic Acid vs Placebo in PSC
NCT03872921 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Novel Association of Cholesterol Ester Storage Disease Due to Lysosomal Acid Lipase Deficiency and Non-Alcoholic Fatty Liver Disease: A Prospective Clinical Study
NCT01791452 ·Status: UNKNOWN